iShares Neuroscience and HeaIBRNETF
13F holders, Q3 2024 (September 30)5holders +1
2new positions
1sold out
$25.02avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, up 1 from Q2 2024. 2 opened new positions and 1 sold out. The largest holders were BlackRock, Inc. ($2.4M), Jane Street Group, LLC ($254K) and Flow Traders U.S. LLC ($244K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $272K |
| Exits | 1 | $2K |
All 13F filers, Q2 2024 → Q3 2024: 11,448 shares bought and 7,700 shares sold, net +3,748 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| BlackRock, Inc. | 0.00% | — | 95,000 | $2.4M |
| Jane Street Group, LLC | 0.00% | New | 10,150 | $254K |
| Flow Traders U.S. LLC | 0.01% | Reduce -43.8% | 9,762 | $244K |
| Bank of Montreal | 0.00% | Add +77.1% | 1,300 | $32K |
| Principal Securities, Inc. | 0.00% | New | 732 | $18K |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.